Moderna testing potential monkeypox vaccines


Moderna testing potential monkeypox vaccines

(Reuters) – Moderna Inc (MRNA.O) is testing potential vaccines against monkeypox in pre-clinical trials as the disease spreads in the United States and Europe.

Test tubes are seen in front of a displayed Moderna logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration

The World Health Organization said on Tuesday there have been 131 confirmed monkeypox cases and 106 further suspected cases since the first was reported on May 7 outside the countries where it usually spreads. read more

Moderna did not immediately respond to a request for more details on the monkeypox vaccines.

The U.S. Centers for Disease Control and Prevention said the government was in the process of releasing doses of a smallpox vaccine Jynneos, made by Bavarian Nordic A/S (BAVA.CO), for use in monkeypox cases. read more

Reporting by Leroy Leo in Bengaluru; Editing by Shounak Dasgupta

Our Standards: The Thomson Reuters Trust Principles.


Reuters source: